Pharmaco - Press Releases

Date	Title	Company
01-Nov-2022	Increasing throughput for pharmaceutical laboratories	Technobis Crystallization Systems
01-Nov-2022	BRIM Biotechnology receives FDA agreement on Phase 3 clinical trial design for BRM421, BRIM’s lead candidate for Dry Eye Disease, at End of Phase 2 Meeting	Sciad Newswire
01-Nov-2022	ProteoNic Announces Broadening of GigaGen’s Rights to 2G UNic™ Technology	B3C newswire
01-Nov-2022	Lonza Launches New Capsule to Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine	Lonza Group AG
01-Nov-2022	ProcCluster® from portfolio company inflamed pharma granted US patent	Xlife Sciences AG
01-Nov-2022	Procurement and supply chain brought together under the new Chief Operations Officer	Zur Rose Group AG
31-Oct-2022	Biophytis publishes its key financial figures as at 30 June 2022, announces a restatement of the financial statements published as of December 31st, 2021 and provides an update on the oper	Biophytis
31-Oct-2022	Aptar Pharma Completes First Phase of Global Expansion Program to Meet Growing Customer Capacity Needs for Injectable Drug Delivery	Aptar Pharma
31-Oct-2022	SynBiotic SE completes successfully capital increase and places all new shares	SynBiotic SE
31-Oct-2022	European Medicines Agency Validates Santhera’s Marketing Authorization Application for Vamorolone in Duchenne Muscular Dystrophy	Santhera Pharmaceuticals
31-Oct-2022	Santhera Announces Half-Year 2022 Financial Results and Provides Corporate Update	Santhera Pharmaceuticals
31-Oct-2022	Preclinical Data Demonstrates SonoTran® Increased Delivery and Efficacy of ADCT-601 in Human Renal Cancer Model	B3C newswire
31-Oct-2022	DEFENCE TO APPLY ITS PROPRIATRY ACCUMTM TECHNOLOGY IN THE DESIGN OF MESSENGER RNA ANTI-CANCER VACCINES	Defence Therapeutics Inc.
30-Oct-2022	Challenging macroeconomic environment impact Fresenius Medical Care and Fresenius Group earnings in FY/22; Fresenius SE & Co. KGaA Group guidance revised	Fresenius SE & Co. KGaA
30-Oct-2022	Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022	Fresenius Medical Care AG & Co. KGaA
30-Oct-2022	Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022	Fresenius Medical Care AG & Co. KGaA
30-Oct-2022	IGEA Pharma N.V.: Igea discloses its 2022 Half-Year Financial Report	IGEA Pharma N.V.
28-Oct-2022	European Medicines Agency validates ViiV Healthcare’s marketing authorisation application for cabotegravir long-acting injectable for HIV Prevention	ViiV Healthcare
28-Oct-2022	Inizio commits to helping limit the impact of climate change and achieving SBTi Net-Zero Standard	Inizio
28-Oct-2022	AEVIS VICTORIA SA – AEVS.SW – Visana enters into the share capital of Hôpital du Jura Bernois, a subsidiary of Swiss Medical Network	AEVIS VICTORIA SA